372
Participants
Start Date
June 30, 2006
Primary Completion Date
December 31, 2011
Study Completion Date
October 31, 2013
IP
irinotecan+cisplatin
Soonchunhyang University Bucheon Hospital, Bucheon-si
Yeungnam University Hospital, Daegu
Daegu Catholic University Hospital, Daegu
Gyeongsang National University Hospital, Jinju
Seoul National University Bundang Hospital, Seongnam-si
Seoul National University Hospital, Seoul
Kangbuk Samsung Hospital, Seoul
Yonsei Cancer Center, Seoul
Seoul Veterans Hospital, Seoul
Kangnam St.Mary's Hospital, Seoul
Asan Medical Center, Seoul
Chung-Ang University Medical Center, Seoul
Seoul Municipal Boramae Hospital, Seoul
St.Vincent Hospital, Suwon
Lead Sponsor
Clinical Research Center for Solid Tumor, Korea
OTHER